| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroesophageal Reflux | 245 | 2021 | 318 | 30.760 |
Why?
|
| Esophagus | 207 | 2019 | 303 | 17.470 |
Why?
|
| Manometry | 183 | 2021 | 276 | 12.420 |
Why?
|
| Esophageal Motility Disorders | 50 | 2021 | 59 | 9.980 |
Why?
|
| Proton Pump Inhibitors | 55 | 2019 | 91 | 9.590 |
Why?
|
| Esophageal Achalasia | 57 | 2021 | 78 | 7.830 |
Why?
|
| Electric Impedance | 51 | 2018 | 131 | 7.690 |
Why?
|
| Deglutition | 57 | 2019 | 221 | 6.470 |
Why?
|
| Gastric Acid | 49 | 2017 | 71 | 6.400 |
Why?
|
| Omeprazole | 45 | 2019 | 53 | 5.930 |
Why?
|
| Hydrogen-Ion Concentration | 125 | 2017 | 618 | 5.280 |
Why?
|
| Anti-Ulcer Agents | 37 | 2008 | 47 | 5.000 |
Why?
|
| Esophagogastric Junction | 105 | 2010 | 118 | 4.920 |
Why?
|
| Deglutition Disorders | 62 | 2021 | 297 | 4.680 |
Why?
|
| Chest Pain | 45 | 2019 | 151 | 4.010 |
Why?
|
| Esophageal Diseases | 64 | 2008 | 95 | 3.660 |
Why?
|
| Esophageal pH Monitoring | 21 | 2018 | 27 | 3.620 |
Why?
|
| Cough | 16 | 2018 | 65 | 3.440 |
Why?
|
| Gastric Acidity Determination | 54 | 2017 | 62 | 3.380 |
Why?
|
| Monitoring, Ambulatory | 33 | 2008 | 84 | 3.160 |
Why?
|
| Barrett Esophagus | 17 | 2018 | 57 | 3.150 |
Why?
|
| Humans | 562 | 2021 | 68618 | 3.020 |
Why?
|
| Esophagitis, Peptic | 26 | 2020 | 33 | 2.990 |
Why?
|
| Catheterization | 37 | 2016 | 209 | 2.980 |
Why?
|
| Histamine H2 Antagonists | 24 | 2015 | 45 | 2.880 |
Why?
|
| Heartburn | 40 | 2019 | 46 | 2.830 |
Why?
|
| Middle Aged | 251 | 2021 | 21147 | 2.630 |
Why?
|
| Gastrointestinal Agents | 15 | 2019 | 51 | 2.600 |
Why?
|
| Adult | 272 | 2019 | 21403 | 2.450 |
Why?
|
| Male | 320 | 2021 | 37321 | 2.400 |
Why?
|
| Female | 276 | 2019 | 38074 | 2.250 |
Why?
|
| Pharynx | 26 | 2009 | 89 | 2.130 |
Why?
|
| Pressure | 98 | 2016 | 252 | 2.010 |
Why?
|
| Peristalsis | 67 | 2015 | 76 | 1.990 |
Why?
|
| Gastrointestinal Motility | 30 | 2010 | 52 | 1.990 |
Why?
|
| Esophageal Spasm, Diffuse | 9 | 2018 | 13 | 1.980 |
Why?
|
| Posture | 21 | 2015 | 107 | 1.930 |
Why?
|
| Aged | 154 | 2019 | 14862 | 1.910 |
Why?
|
| Enzyme Inhibitors | 17 | 2006 | 659 | 1.720 |
Why?
|
| Esophageal Sphincter, Lower | 8 | 2019 | 22 | 1.520 |
Why?
|
| Ranitidine | 9 | 2015 | 16 | 1.520 |
Why?
|
| Fundoplication | 12 | 2019 | 27 | 1.510 |
Why?
|
| Monitoring, Physiologic | 30 | 2008 | 219 | 1.480 |
Why?
|
| Circadian Rhythm | 16 | 2005 | 218 | 1.440 |
Why?
|
| Dilatation | 11 | 2019 | 58 | 1.440 |
Why?
|
| Aged, 80 and over | 46 | 2016 | 4848 | 1.260 |
Why?
|
| Muscle Contraction | 29 | 2012 | 210 | 1.190 |
Why?
|
| Retrospective Studies | 44 | 2019 | 7277 | 1.180 |
Why?
|
| Time Factors | 49 | 2019 | 4655 | 1.160 |
Why?
|
| Reference Values | 31 | 2008 | 579 | 1.160 |
Why?
|
| Esophagoscopy | 24 | 2018 | 72 | 1.150 |
Why?
|
| Muscle, Smooth | 31 | 2007 | 117 | 1.100 |
Why?
|
| Sleep | 6 | 2015 | 263 | 1.080 |
Why?
|
| Adolescent | 55 | 2016 | 8912 | 1.030 |
Why?
|
| Botulinum Toxins | 5 | 2018 | 18 | 1.020 |
Why?
|
| Severity of Illness Index | 16 | 2018 | 1851 | 1.010 |
Why?
|
| Supine Position | 6 | 2015 | 11 | 0.990 |
Why?
|
| Esophagitis | 13 | 2004 | 45 | 0.940 |
Why?
|
| Antacids | 23 | 2020 | 26 | 0.930 |
Why?
|
| Gastroenterology | 6 | 2016 | 98 | 0.920 |
Why?
|
| Postprandial Period | 7 | 2009 | 21 | 0.900 |
Why?
|
| Plant Oils | 3 | 2019 | 31 | 0.880 |
Why?
|
| Cross-Over Studies | 19 | 2015 | 260 | 0.870 |
Why?
|
| Gastric Juice | 20 | 2012 | 27 | 0.840 |
Why?
|
| Treatment Outcome | 26 | 2019 | 7029 | 0.800 |
Why?
|
| Gastrointestinal Transit | 7 | 2012 | 16 | 0.800 |
Why?
|
| Double-Blind Method | 30 | 2015 | 1738 | 0.790 |
Why?
|
| Larynx | 2 | 2018 | 49 | 0.780 |
Why?
|
| Diagnosis, Differential | 28 | 2015 | 1140 | 0.780 |
Why?
|
| Nonprescription Drugs | 2 | 2017 | 28 | 0.780 |
Why?
|
| Sensitivity and Specificity | 20 | 2016 | 1753 | 0.770 |
Why?
|
| Bethanechol | 9 | 2009 | 11 | 0.760 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 19 | 2016 | 23 | 0.760 |
Why?
|
| Plethysmography, Impedance | 6 | 2012 | 17 | 0.710 |
Why?
|
| Long Term Adverse Effects | 1 | 2019 | 6 | 0.700 |
Why?
|
| Laryngopharyngeal Reflux | 3 | 2017 | 5 | 0.690 |
Why?
|
| Pain | 21 | 1997 | 472 | 0.690 |
Why?
|
| Barium Sulfate | 10 | 2016 | 66 | 0.690 |
Why?
|
| Pharyngeal Diseases | 5 | 2012 | 21 | 0.670 |
Why?
|
| Drug Therapy, Combination | 15 | 2019 | 649 | 0.660 |
Why?
|
| Eating | 10 | 2005 | 119 | 0.630 |
Why?
|
| Drug Administration Schedule | 15 | 2018 | 567 | 0.620 |
Why?
|
| Stomach | 11 | 2006 | 80 | 0.620 |
Why?
|
| Asthma | 9 | 2011 | 345 | 0.600 |
Why?
|
| Pain Threshold | 7 | 1998 | 55 | 0.600 |
Why?
|
| Polyps | 1 | 2017 | 12 | 0.590 |
Why?
|
| Laparoscopy | 5 | 2013 | 237 | 0.590 |
Why?
|
| Symptom Assessment | 1 | 2017 | 33 | 0.590 |
Why?
|
| Lansoprazole | 15 | 2004 | 16 | 0.590 |
Why?
|
| Sulfoxides | 4 | 2006 | 16 | 0.590 |
Why?
|
| Prospective Studies | 25 | 2018 | 3705 | 0.580 |
Why?
|
| Delphi Technique | 1 | 2017 | 62 | 0.570 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 64 | 0.570 |
Why?
|
| Thorax | 13 | 1987 | 49 | 0.560 |
Why?
|
| Benzimidazoles | 4 | 2006 | 128 | 0.540 |
Why?
|
| Follow-Up Studies | 20 | 2016 | 3259 | 0.540 |
Why?
|
| Gastrins | 19 | 1997 | 27 | 0.520 |
Why?
|
| Gastric Mucosa | 13 | 1999 | 77 | 0.520 |
Why?
|
| Peptic Ulcer | 8 | 2005 | 37 | 0.520 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2015 | 30 | 0.500 |
Why?
|
| Oropharynx | 6 | 2012 | 20 | 0.490 |
Why?
|
| Neuromuscular Agents | 1 | 2015 | 22 | 0.490 |
Why?
|
| Food | 7 | 2005 | 52 | 0.490 |
Why?
|
| Scleroderma, Systemic | 9 | 2007 | 446 | 0.480 |
Why?
|
| Gastric Emptying | 13 | 2004 | 24 | 0.480 |
Why?
|
| Contrast Media | 5 | 2016 | 595 | 0.480 |
Why?
|
| Radiography | 25 | 2015 | 572 | 0.470 |
Why?
|
| Hydrochloric Acid | 11 | 1998 | 19 | 0.470 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 438 | 0.470 |
Why?
|
| Prevalence | 8 | 2018 | 1619 | 0.460 |
Why?
|
| Fiber Optic Technology | 3 | 2013 | 40 | 0.450 |
Why?
|
| Predictive Value of Tests | 7 | 2018 | 1465 | 0.450 |
Why?
|
| Fasting | 9 | 2006 | 75 | 0.430 |
Why?
|
| Intubation, Gastrointestinal | 6 | 2000 | 48 | 0.430 |
Why?
|
| Young Adult | 13 | 2016 | 5717 | 0.430 |
Why?
|
| Obesity | 4 | 2020 | 1076 | 0.410 |
Why?
|
| Administration, Oral | 12 | 2009 | 411 | 0.400 |
Why?
|
| Clinical Competence | 2 | 2016 | 657 | 0.400 |
Why?
|
| Esomeprazole | 4 | 2006 | 9 | 0.390 |
Why?
|
| Mentha piperita | 3 | 2019 | 6 | 0.390 |
Why?
|
| Sleep Wake Disorders | 1 | 2012 | 94 | 0.390 |
Why?
|
| Hernia, Hiatal | 7 | 2005 | 18 | 0.390 |
Why?
|
| Chronic Disease | 20 | 2009 | 1330 | 0.390 |
Why?
|
| Probability | 6 | 2008 | 245 | 0.380 |
Why?
|
| Risk Assessment | 7 | 2017 | 2007 | 0.380 |
Why?
|
| Viscosity | 6 | 2013 | 72 | 0.380 |
Why?
|
| Bethanechol Compounds | 20 | 1987 | 20 | 0.370 |
Why?
|
| Diagnostic Techniques, Digestive System | 3 | 2007 | 6 | 0.370 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 1999 | 12 | 0.370 |
Why?
|
| Parkinson Disease | 3 | 2001 | 272 | 0.370 |
Why?
|
| Mentors | 1 | 2011 | 81 | 0.370 |
Why?
|
| Endoscopy, Digestive System | 4 | 2017 | 78 | 0.360 |
Why?
|
| Analysis of Variance | 12 | 2012 | 1040 | 0.360 |
Why?
|
| Career Choice | 1 | 2011 | 98 | 0.360 |
Why?
|
| Serotonin Receptor Agonists | 2 | 2009 | 34 | 0.350 |
Why?
|
| Baclofen | 3 | 2019 | 24 | 0.350 |
Why?
|
| Alginates | 6 | 2020 | 35 | 0.350 |
Why?
|
| Cohort Studies | 8 | 2008 | 2358 | 0.340 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2005 | 185 | 0.340 |
Why?
|
| Edrophonium | 15 | 1994 | 15 | 0.340 |
Why?
|
| Prodrugs | 1 | 2009 | 54 | 0.340 |
Why?
|
| Risk Factors | 13 | 2016 | 5731 | 0.340 |
Why?
|
| Teaching | 1 | 2011 | 169 | 0.340 |
Why?
|
| Cimetidine | 13 | 1995 | 25 | 0.330 |
Why?
|
| Laryngitis | 3 | 1999 | 12 | 0.330 |
Why?
|
| Pyridostigmine Bromide | 1 | 2009 | 11 | 0.330 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2006 | 28 | 0.330 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2009 | 1745 | 0.330 |
Why?
|
| Buspirone | 1 | 2009 | 36 | 0.330 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 102 | 0.320 |
Why?
|
| Equipment Design | 6 | 2015 | 500 | 0.310 |
Why?
|
| Laryngeal Diseases | 3 | 2011 | 22 | 0.310 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2018 | 45 | 0.310 |
Why?
|
| Dyspareunia | 1 | 2008 | 7 | 0.310 |
Why?
|
| Subclavian Artery | 2 | 2021 | 30 | 0.310 |
Why?
|
| Anti-Dyskinesia Agents | 2 | 1999 | 3 | 0.300 |
Why?
|
| Esophageal Neoplasms | 8 | 2017 | 150 | 0.300 |
Why?
|
| Calcium Channel Blockers | 5 | 2018 | 138 | 0.300 |
Why?
|
| Sensation | 6 | 1998 | 49 | 0.300 |
Why?
|
| Electrodes | 7 | 2003 | 147 | 0.300 |
Why?
|
| Indoles | 2 | 2006 | 146 | 0.300 |
Why?
|
| Mechanoreceptors | 3 | 1997 | 11 | 0.300 |
Why?
|
| Reproducibility of Results | 9 | 2013 | 2077 | 0.300 |
Why?
|
| Recurrence | 7 | 2019 | 948 | 0.290 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2019 | 5 | 0.290 |
Why?
|
| Muscarinic Agonists | 1 | 2007 | 17 | 0.290 |
Why?
|
| Chemoreceptor Cells | 2 | 1997 | 5 | 0.290 |
Why?
|
| Aluminum Hydroxide | 2 | 2020 | 3 | 0.290 |
Why?
|
| Sodium Bicarbonate | 2 | 2020 | 5 | 0.290 |
Why?
|
| Silicic Acid | 2 | 2020 | 4 | 0.290 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2006 | 100 | 0.280 |
Why?
|
| Nifedipine | 5 | 1992 | 40 | 0.280 |
Why?
|
| Feeding Behavior | 4 | 2005 | 224 | 0.280 |
Why?
|
| Proton-Translocating ATPases | 1 | 2006 | 9 | 0.280 |
Why?
|
| Age Factors | 11 | 2013 | 1864 | 0.270 |
Why?
|
| Dyspepsia | 2 | 1999 | 8 | 0.270 |
Why?
|
| Hypopharynx | 2 | 2004 | 2 | 0.270 |
Why?
|
| Ambulatory Care | 8 | 2007 | 340 | 0.270 |
Why?
|
| Single-Blind Method | 6 | 2012 | 249 | 0.260 |
Why?
|
| Carbolines | 1 | 2005 | 19 | 0.260 |
Why?
|
| Sex Factors | 8 | 2013 | 1266 | 0.260 |
Why?
|
| Beverages | 2 | 2005 | 50 | 0.260 |
Why?
|
| South Carolina | 3 | 2018 | 2752 | 0.260 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 2800 | 0.260 |
Why?
|
| Evoked Potentials | 4 | 1996 | 61 | 0.260 |
Why?
|
| Child | 12 | 2011 | 6405 | 0.260 |
Why?
|
| Duodenogastric Reflux | 2 | 1996 | 2 | 0.250 |
Why?
|
| Sensory Thresholds | 4 | 1999 | 50 | 0.250 |
Why?
|
| Esophageal Sphincter, Upper | 3 | 2009 | 7 | 0.250 |
Why?
|
| Life Style | 5 | 2005 | 338 | 0.250 |
Why?
|
| ROC Curve | 3 | 2012 | 392 | 0.250 |
Why?
|
| Imidazoles | 1 | 2005 | 175 | 0.250 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2004 | 1 | 0.240 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2004 | 2 | 0.240 |
Why?
|
| Statistics, Nonparametric | 6 | 2007 | 306 | 0.240 |
Why?
|
| Disease Progression | 4 | 2017 | 1038 | 0.240 |
Why?
|
| Piperazines | 1 | 2005 | 206 | 0.230 |
Why?
|
| Voice Disorders | 1 | 2004 | 22 | 0.230 |
Why?
|
| Helicobacter Infections | 1 | 2004 | 40 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 4 | 1997 | 107 | 0.230 |
Why?
|
| Angina Pectoris | 4 | 1992 | 61 | 0.230 |
Why?
|
| Helicobacter pylori | 1 | 2004 | 54 | 0.230 |
Why?
|
| Recovery of Function | 2 | 2019 | 506 | 0.220 |
Why?
|
| Aging | 7 | 1998 | 911 | 0.220 |
Why?
|
| Diet | 7 | 2003 | 514 | 0.220 |
Why?
|
| GABA Agonists | 1 | 2003 | 23 | 0.220 |
Why?
|
| Chi-Square Distribution | 5 | 2008 | 546 | 0.210 |
Why?
|
| Proton Pumps | 2 | 2000 | 13 | 0.210 |
Why?
|
| Eructation | 3 | 1998 | 3 | 0.210 |
Why?
|
| Cisapride | 2 | 1999 | 4 | 0.210 |
Why?
|
| Incidence | 6 | 2008 | 1603 | 0.210 |
Why?
|
| Muscle Relaxation | 5 | 2004 | 31 | 0.210 |
Why?
|
| Famotidine | 1 | 2002 | 1 | 0.210 |
Why?
|
| Prostheses and Implants | 5 | 1997 | 159 | 0.210 |
Why?
|
| Wound Healing | 2 | 2002 | 260 | 0.210 |
Why?
|
| Risk Reduction Behavior | 1 | 2003 | 174 | 0.200 |
Why?
|
| Case-Control Studies | 6 | 2008 | 1553 | 0.200 |
Why?
|
| Disease Management | 1 | 2003 | 248 | 0.200 |
Why?
|
| Menstrual Cycle | 2 | 1999 | 64 | 0.200 |
Why?
|
| Medical History Taking | 3 | 2015 | 94 | 0.190 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2021 | 15 | 0.190 |
Why?
|
| Drug Combinations | 2 | 2020 | 304 | 0.190 |
Why?
|
| Sucralfate | 4 | 1988 | 4 | 0.190 |
Why?
|
| Infant | 6 | 2007 | 2891 | 0.190 |
Why?
|
| Lewy Bodies | 1 | 2001 | 7 | 0.190 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2008 | 171 | 0.190 |
Why?
|
| Food-Drug Interactions | 1 | 2000 | 4 | 0.190 |
Why?
|
| Spasm | 11 | 1995 | 18 | 0.180 |
Why?
|
| Animals | 41 | 2003 | 20881 | 0.180 |
Why?
|
| Dilatation, Pathologic | 2 | 2016 | 58 | 0.180 |
Why?
|
| Video Recording | 2 | 1998 | 145 | 0.180 |
Why?
|
| Parasympatholytics | 6 | 2006 | 19 | 0.180 |
Why?
|
| Bile | 2 | 2017 | 35 | 0.180 |
Why?
|
| Treatment Failure | 3 | 2008 | 216 | 0.170 |
Why?
|
| Transducers, Pressure | 6 | 2008 | 14 | 0.170 |
Why?
|
| Luteinizing Hormone | 1 | 1999 | 31 | 0.170 |
Why?
|
| Dicyclomine | 1 | 1999 | 1 | 0.170 |
Why?
|
| Prostaglandins | 5 | 1982 | 65 | 0.170 |
Why?
|
| Cardia | 2 | 1998 | 4 | 0.170 |
Why?
|
| Sex Distribution | 3 | 2008 | 274 | 0.170 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 17 | 0.170 |
Why?
|
| Electrodiagnosis | 3 | 2012 | 12 | 0.170 |
Why?
|
| Software | 4 | 2015 | 418 | 0.160 |
Why?
|
| Age Distribution | 3 | 2008 | 320 | 0.160 |
Why?
|
| Octreotide | 1 | 1999 | 21 | 0.160 |
Why?
|
| Radionuclide Imaging | 13 | 1990 | 166 | 0.160 |
Why?
|
| Choristoma | 1 | 1998 | 20 | 0.160 |
Why?
|
| Transducers | 8 | 2005 | 21 | 0.160 |
Why?
|
| Progesterone | 2 | 1999 | 115 | 0.160 |
Why?
|
| Conversion Disorder | 1 | 1998 | 2 | 0.160 |
Why?
|
| Microcomputers | 5 | 1991 | 32 | 0.160 |
Why?
|
| Mucous Membrane | 9 | 2000 | 66 | 0.160 |
Why?
|
| Cats | 11 | 1998 | 292 | 0.160 |
Why?
|
| Nitroglycerin | 3 | 2006 | 20 | 0.160 |
Why?
|
| Imipramine | 1 | 1998 | 44 | 0.160 |
Why?
|
| Barium Radioisotopes | 1 | 2018 | 3 | 0.160 |
Why?
|
| Isosorbide Dinitrate | 1 | 2018 | 6 | 0.160 |
Why?
|
| Terminology as Topic | 2 | 2018 | 141 | 0.160 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 475 | 0.160 |
Why?
|
| Myotomy | 1 | 2018 | 14 | 0.150 |
Why?
|
| Pirenzepine | 4 | 1992 | 17 | 0.150 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2018 | 25 | 0.150 |
Why?
|
| Complementary Therapies | 1 | 2018 | 43 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2019 | 1342 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2005 | 931 | 0.150 |
Why?
|
| Nitric Oxide Donors | 1 | 2018 | 54 | 0.150 |
Why?
|
| Computers | 4 | 1987 | 63 | 0.150 |
Why?
|
| Muscles | 5 | 1986 | 158 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2003 | 403 | 0.150 |
Why?
|
| Receptors, Histamine H2 | 2 | 1988 | 4 | 0.150 |
Why?
|
| Piperidines | 1 | 1998 | 123 | 0.150 |
Why?
|
| Esophageal Stenosis | 5 | 1990 | 36 | 0.150 |
Why?
|
| Documentation | 1 | 2018 | 83 | 0.150 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 1997 | 6 | 0.150 |
Why?
|
| Esophageal Mucosa | 1 | 2017 | 2 | 0.140 |
Why?
|
| Drug Resistance | 4 | 2019 | 223 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2018 | 111 | 0.140 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 951 | 0.140 |
Why?
|
| Sex Characteristics | 2 | 1998 | 295 | 0.140 |
Why?
|
| United States | 7 | 2019 | 7367 | 0.140 |
Why?
|
| Liver Cirrhosis | 13 | 1976 | 301 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 2 | 1988 | 43 | 0.140 |
Why?
|
| Dietary Fats | 8 | 1996 | 103 | 0.140 |
Why?
|
| Intestinal Mucosa | 4 | 2004 | 219 | 0.140 |
Why?
|
| Child, Preschool | 4 | 2007 | 3187 | 0.140 |
Why?
|
| Metoclopramide | 9 | 1987 | 21 | 0.140 |
Why?
|
| Learning Curve | 1 | 2016 | 20 | 0.140 |
Why?
|
| Diphosphonates | 1 | 1996 | 39 | 0.140 |
Why?
|
| Benzodiazepinones | 2 | 1986 | 4 | 0.140 |
Why?
|
| Pepsin A | 2 | 2011 | 8 | 0.140 |
Why?
|
| Muscle Tonus | 4 | 1992 | 9 | 0.140 |
Why?
|
| Hoarseness | 3 | 2011 | 6 | 0.130 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2015 | 2 | 0.130 |
Why?
|
| Observer Variation | 2 | 2015 | 330 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 1998 | 286 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2012 | 867 | 0.130 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2015 | 31 | 0.130 |
Why?
|
| Pain Measurement | 1 | 1996 | 328 | 0.130 |
Why?
|
| Papio | 9 | 1985 | 27 | 0.130 |
Why?
|
| Cacao | 4 | 1988 | 11 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2015 | 44 | 0.130 |
Why?
|
| Guanidines | 3 | 1980 | 32 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 446 | 0.120 |
Why?
|
| History, 20th Century | 2 | 2010 | 248 | 0.120 |
Why?
|
| Prostaglandins E | 4 | 1982 | 54 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 67 | 0.120 |
Why?
|
| Bicarbonates | 4 | 1992 | 21 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 1997 | 383 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 866 | 0.120 |
Why?
|
| Retreatment | 3 | 2006 | 59 | 0.120 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1993 | 8 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2002 | 940 | 0.110 |
Why?
|
| Artifacts | 2 | 2013 | 125 | 0.110 |
Why?
|
| Monoamine Oxidase | 4 | 1976 | 26 | 0.110 |
Why?
|
| Sucrose | 1 | 1993 | 58 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 504 | 0.110 |
Why?
|
| Percussion | 5 | 1979 | 5 | 0.110 |
Why?
|
| Health Personnel | 1 | 2016 | 286 | 0.110 |
Why?
|
| Running | 2 | 1990 | 20 | 0.110 |
Why?
|
| Electrophysiology | 2 | 2005 | 160 | 0.110 |
Why?
|
| Triglycerides | 1 | 1993 | 184 | 0.110 |
Why?
|
| Pentagastrin | 12 | 1983 | 16 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 1990 | 240 | 0.110 |
Why?
|
| Consciousness | 1 | 2012 | 17 | 0.110 |
Why?
|
| Injections | 2 | 2006 | 119 | 0.110 |
Why?
|
| Students, Medical | 1 | 2015 | 210 | 0.110 |
Why?
|
| Actigraphy | 1 | 2012 | 28 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2015 | 322 | 0.110 |
Why?
|
| Vagus Nerve | 3 | 1992 | 90 | 0.110 |
Why?
|
| Fatty Acids | 1 | 1993 | 222 | 0.110 |
Why?
|
| Random Allocation | 7 | 2015 | 442 | 0.100 |
Why?
|
| Propantheline | 3 | 1987 | 3 | 0.100 |
Why?
|
| Saliva | 1 | 1993 | 142 | 0.100 |
Why?
|
| Zenker Diverticulum | 1 | 1992 | 7 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 1994 | 211 | 0.100 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1992 | 13 | 0.100 |
Why?
|
| Stimulation, Chemical | 7 | 2001 | 57 | 0.100 |
Why?
|
| Endoscopy | 10 | 2005 | 464 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 378 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 1992 | 26 | 0.100 |
Why?
|
| Diltiazem | 3 | 1991 | 26 | 0.100 |
Why?
|
| Rectum | 2 | 1990 | 62 | 0.100 |
Why?
|
| Area Under Curve | 1 | 2012 | 238 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.100 |
Why?
|
| Quality of Life | 6 | 2019 | 1515 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 1992 | 97 | 0.090 |
Why?
|
| Duodenal Ulcer | 5 | 1981 | 16 | 0.090 |
Why?
|
| Ulcer | 3 | 1997 | 27 | 0.090 |
Why?
|
| Brain | 2 | 1992 | 2176 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 237 | 0.090 |
Why?
|
| Computer Systems | 2 | 1990 | 42 | 0.090 |
Why?
|
| Proctitis | 1 | 1990 | 2 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 7 | 1989 | 219 | 0.090 |
Why?
|
| Overweight | 1 | 2012 | 186 | 0.090 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1990 | 22 | 0.090 |
Why?
|
| Laser Therapy | 1 | 1990 | 54 | 0.090 |
Why?
|
| Clinical Trials as Topic | 11 | 1995 | 848 | 0.090 |
Why?
|
| Prognosis | 2 | 2013 | 2093 | 0.090 |
Why?
|
| Prostaglandins E, Synthetic | 2 | 1988 | 5 | 0.090 |
Why?
|
| Disease-Free Survival | 2 | 2003 | 349 | 0.090 |
Why?
|
| Ammonia | 8 | 1971 | 28 | 0.090 |
Why?
|
| Reflex, Abnormal | 1 | 1989 | 6 | 0.090 |
Why?
|
| Algorithms | 4 | 2006 | 1196 | 0.090 |
Why?
|
| Epoprostenol | 4 | 1982 | 71 | 0.090 |
Why?
|
| Heart Diseases | 2 | 2000 | 276 | 0.090 |
Why?
|
| Gastrointestinal Hormones | 5 | 1979 | 5 | 0.080 |
Why?
|
| Lung | 1 | 1994 | 849 | 0.080 |
Why?
|
| Airway Obstruction | 1 | 1989 | 49 | 0.080 |
Why?
|
| Disease Models, Animal | 5 | 1992 | 2550 | 0.080 |
Why?
|
| Biopsy | 4 | 2016 | 540 | 0.080 |
Why?
|
| Physical Exertion | 1 | 1989 | 75 | 0.080 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2008 | 7 | 0.080 |
Why?
|
| Fluoroscopy | 3 | 2008 | 152 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 58 | 0.080 |
Why?
|
| Neuroglia | 1 | 2009 | 136 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2008 | 737 | 0.080 |
Why?
|
| Autoimmunity | 1 | 2009 | 118 | 0.080 |
Why?
|
| Coitus | 1 | 2008 | 12 | 0.080 |
Why?
|
| Drug Tolerance | 1 | 2008 | 80 | 0.080 |
Why?
|
| Salivation | 2 | 1987 | 7 | 0.080 |
Why?
|
| Gastroscopy | 2 | 2008 | 45 | 0.080 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 27 | 0.080 |
Why?
|
| Vagotomy | 4 | 1976 | 9 | 0.080 |
Why?
|
| Aminophylline | 1 | 1987 | 2 | 0.070 |
Why?
|
| Terbutaline | 1 | 1987 | 23 | 0.070 |
Why?
|
| Pregnancy | 5 | 1999 | 2334 | 0.070 |
Why?
|
| Anemia, Pernicious | 4 | 1975 | 11 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2001 | 275 | 0.070 |
Why?
|
| Water | 6 | 2007 | 230 | 0.070 |
Why?
|
| Infusions, Parenteral | 6 | 1985 | 47 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2013 | 596 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 136 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 1990 | 415 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2009 | 434 | 0.070 |
Why?
|
| Ascites | 2 | 1982 | 38 | 0.070 |
Why?
|
| Parasympathomimetics | 3 | 1976 | 13 | 0.070 |
Why?
|
| Receptors, Histamine | 1 | 1986 | 3 | 0.070 |
Why?
|
| Verapamil | 2 | 1985 | 30 | 0.070 |
Why?
|
| Food Hypersensitivity | 2 | 1978 | 20 | 0.070 |
Why?
|
| Vardenafil Dihydrochloride | 1 | 2005 | 2 | 0.070 |
Why?
|
| Tadalafil | 1 | 2005 | 4 | 0.070 |
Why?
|
| Biopolymers | 1 | 2006 | 21 | 0.070 |
Why?
|
| Dosage Forms | 1 | 2005 | 20 | 0.070 |
Why?
|
| Isoenzymes | 3 | 1976 | 308 | 0.070 |
Why?
|
| Parietal Cells, Gastric | 1 | 2005 | 23 | 0.070 |
Why?
|
| Sildenafil Citrate | 1 | 2005 | 23 | 0.070 |
Why?
|
| Acids | 4 | 1997 | 12 | 0.070 |
Why?
|
| Epithelium | 2 | 2001 | 172 | 0.070 |
Why?
|
| Purines | 1 | 2005 | 39 | 0.070 |
Why?
|
| Macaca mulatta | 8 | 1988 | 77 | 0.070 |
Why?
|
| Health Care Costs | 2 | 2001 | 346 | 0.070 |
Why?
|
| Sulfones | 1 | 2005 | 45 | 0.070 |
Why?
|
| Lidocaine | 1 | 1985 | 36 | 0.060 |
Why?
|
| Hypertension, Portal | 5 | 1978 | 53 | 0.060 |
Why?
|
| Powders | 1 | 2005 | 32 | 0.060 |
Why?
|
| Disposable Equipment | 1 | 2005 | 12 | 0.060 |
Why?
|
| Ultrasonography | 4 | 1993 | 453 | 0.060 |
Why?
|
| Liver | 4 | 1979 | 1118 | 0.060 |
Why?
|
| Triazines | 1 | 2005 | 48 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 138 | 0.060 |
Why?
|
| Behavior Therapy | 3 | 2018 | 297 | 0.060 |
Why?
|
| Endosonography | 1 | 2006 | 177 | 0.060 |
Why?
|
| Diabetic Neuropathies | 3 | 1985 | 33 | 0.060 |
Why?
|
| Placebos | 3 | 1997 | 195 | 0.060 |
Why?
|
| Liver Circulation | 5 | 1969 | 40 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 216 | 0.060 |
Why?
|
| Hyperplasia | 3 | 1990 | 89 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 2 | 1985 | 22 | 0.060 |
Why?
|
| Urban Health | 1 | 2004 | 49 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 329 | 0.060 |
Why?
|
| Benzazepines | 1 | 1984 | 104 | 0.060 |
Why?
|
| Indomethacin | 4 | 1988 | 107 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2005 | 392 | 0.060 |
Why?
|
| Bloodletting | 1 | 1983 | 1 | 0.060 |
Why?
|
| Polycythemia | 1 | 1983 | 3 | 0.060 |
Why?
|
| False Positive Reactions | 3 | 1993 | 95 | 0.060 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1983 | 20 | 0.060 |
Why?
|
| Hodgkin Disease | 2 | 1981 | 27 | 0.050 |
Why?
|
| Hexuronic Acids | 3 | 1991 | 24 | 0.050 |
Why?
|
| Glucuronic Acid | 3 | 1991 | 25 | 0.050 |
Why?
|
| Diverticulum, Esophageal | 1 | 1982 | 4 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 1046 | 0.050 |
Why?
|
| Haplorhini | 9 | 1984 | 44 | 0.050 |
Why?
|
| Drug Interactions | 2 | 2002 | 289 | 0.050 |
Why?
|
| Bilirubin | 3 | 2004 | 51 | 0.050 |
Why?
|
| Methacholine Compounds | 3 | 1976 | 7 | 0.050 |
Why?
|
| Patient Selection | 1 | 2006 | 592 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 1982 | 40 | 0.050 |
Why?
|
| Dogs | 3 | 1990 | 490 | 0.050 |
Why?
|
| Cold Temperature | 1 | 1981 | 90 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2003 | 319 | 0.050 |
Why?
|
| Reaction Time | 2 | 1993 | 170 | 0.050 |
Why?
|
| Body Weight | 5 | 1994 | 554 | 0.050 |
Why?
|
| Therapeutic Equivalency | 1 | 2001 | 21 | 0.050 |
Why?
|
| Hyperthermia, Induced | 1 | 2002 | 53 | 0.050 |
Why?
|
| Lymphoma | 1 | 1982 | 116 | 0.050 |
Why?
|
| Weight Loss | 2 | 1996 | 319 | 0.050 |
Why?
|
| Physical Examination | 1 | 1982 | 152 | 0.050 |
Why?
|
| Agranulocytosis | 1 | 1980 | 15 | 0.050 |
Why?
|
| Barium | 2 | 1997 | 52 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2001 | 260 | 0.050 |
Why?
|
| Periodicity | 1 | 2001 | 43 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 1981 | 80 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2001 | 238 | 0.050 |
Why?
|
| Eosinophilia | 1 | 1980 | 47 | 0.050 |
Why?
|
| Respiratory Function Tests | 2 | 1994 | 123 | 0.050 |
Why?
|
| Neutropenia | 1 | 1980 | 72 | 0.050 |
Why?
|
| Gastric Fundus | 2 | 1990 | 8 | 0.040 |
Why?
|
| Famous Persons | 1 | 1980 | 15 | 0.040 |
Why?
|
| Anorexia Nervosa | 2 | 1979 | 52 | 0.040 |
Why?
|
| Blood Circulation Time | 2 | 1978 | 3 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 211 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2021 | 136 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1999 | 22 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 1980 | 122 | 0.040 |
Why?
|
| Hemodynamics | 2 | 1985 | 705 | 0.040 |
Why?
|
| Remission, Spontaneous | 2 | 1999 | 25 | 0.040 |
Why?
|
| Acute Disease | 3 | 1998 | 658 | 0.040 |
Why?
|
| Desipramine | 1 | 2019 | 47 | 0.040 |
Why?
|
| Prone Position | 1 | 1999 | 8 | 0.040 |
Why?
|
| Muscle Relaxants, Central | 1 | 2019 | 13 | 0.040 |
Why?
|
| Pyloric Antrum | 3 | 1976 | 10 | 0.040 |
Why?
|
| Liver Diseases | 4 | 1977 | 193 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 102 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2019 | 13 | 0.040 |
Why?
|
| Metaplasia | 1 | 1999 | 27 | 0.040 |
Why?
|
| Nutrition Disorders | 1 | 1979 | 16 | 0.040 |
Why?
|
| Atropine | 4 | 1987 | 29 | 0.040 |
Why?
|
| Hypertension | 3 | 1980 | 1535 | 0.040 |
Why?
|
| Smoking | 4 | 1994 | 1452 | 0.040 |
Why?
|
| Receptors, Cholinergic | 2 | 1976 | 30 | 0.040 |
Why?
|
| Interleukins | 1 | 2019 | 79 | 0.040 |
Why?
|
| Chlorpheniramine | 1 | 1978 | 1 | 0.040 |
Why?
|
| Analog-Digital Conversion | 1 | 1998 | 2 | 0.040 |
Why?
|
| Cell Division | 1 | 1999 | 541 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2019 | 62 | 0.040 |
Why?
|
| Air | 1 | 1998 | 22 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2019 | 75 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2004 | 767 | 0.040 |
Why?
|
| Neural Conduction | 2 | 1977 | 24 | 0.040 |
Why?
|
| Acid-Base Imbalance | 1 | 1998 | 3 | 0.040 |
Why?
|
| Coronary Disease | 1 | 1980 | 358 | 0.040 |
Why?
|
| Histamine | 1 | 1978 | 52 | 0.040 |
Why?
|
| Zollinger-Ellison Syndrome | 4 | 1981 | 4 | 0.040 |
Why?
|
| Pharyngeal Muscles | 2 | 1995 | 10 | 0.040 |
Why?
|
| California | 1 | 2018 | 99 | 0.040 |
Why?
|
| Decision Trees | 1 | 2018 | 74 | 0.040 |
Why?
|
| Auscultation | 1 | 1977 | 4 | 0.040 |
Why?
|
| Fatty Liver | 3 | 1967 | 97 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 2279 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 442 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2019 | 241 | 0.040 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.040 |
Why?
|
| Gastrectomy | 2 | 1975 | 24 | 0.040 |
Why?
|
| Calibration | 1 | 1997 | 73 | 0.040 |
Why?
|
| Abdomen | 1 | 1977 | 80 | 0.040 |
Why?
|
| Digestive System Neoplasms | 1 | 1997 | 13 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 1977 | 22 | 0.040 |
Why?
|
| Selection Bias | 1 | 1997 | 23 | 0.040 |
Why?
|
| Systole | 2 | 1992 | 149 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 1997 | 18 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 330 | 0.040 |
Why?
|
| Capsules | 1 | 1997 | 18 | 0.040 |
Why?
|
| Sleep Stages | 1 | 1997 | 30 | 0.040 |
Why?
|
| Viscera | 1 | 1997 | 16 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 1996 | 9 | 0.040 |
Why?
|
| Alendronate | 1 | 1996 | 4 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 1997 | 120 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1996 | 20 | 0.040 |
Why?
|
| Ion-Selective Electrodes | 1 | 1996 | 2 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1997 | 59 | 0.030 |
Why?
|
| Mouth Neoplasms | 1 | 1979 | 206 | 0.030 |
Why?
|
| Safety | 1 | 1997 | 145 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1999 | 597 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.030 |
Why?
|
| Blood Pressure | 4 | 1992 | 1451 | 0.030 |
Why?
|
| Body Height | 2 | 1994 | 67 | 0.030 |
Why?
|
| Perfusion | 5 | 1989 | 131 | 0.030 |
Why?
|
| Caffeine | 2 | 1975 | 81 | 0.030 |
Why?
|
| Electroencephalography | 2 | 1990 | 418 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 626 | 0.030 |
Why?
|
| Eosinophils | 1 | 2016 | 60 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2016 | 35 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 1996 | 45 | 0.030 |
Why?
|
| False Negative Reactions | 2 | 1989 | 63 | 0.030 |
Why?
|
| Portacaval Shunt, Surgical | 3 | 1972 | 5 | 0.030 |
Why?
|
| Sialorrhea | 1 | 1995 | 7 | 0.030 |
Why?
|
| Alkalies | 3 | 1979 | 6 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 1999 | 1034 | 0.030 |
Why?
|
| Diagnosis | 2 | 1965 | 15 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 228 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 1995 | 63 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1995 | 43 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 204 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 1997 | 772 | 0.030 |
Why?
|
| Duodenum | 1 | 1975 | 47 | 0.030 |
Why?
|
| Hepatitis A | 3 | 1972 | 8 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1995 | 17 | 0.030 |
Why?
|
| Methods | 5 | 1992 | 156 | 0.030 |
Why?
|
| Schistosomiasis | 3 | 1974 | 6 | 0.030 |
Why?
|
| Psychophysiologic Disorders | 1 | 1994 | 20 | 0.030 |
Why?
|
| Mathematics | 2 | 1991 | 83 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1994 | 17 | 0.030 |
Why?
|
| Rubber | 1 | 1994 | 13 | 0.030 |
Why?
|
| Premedication | 2 | 1985 | 49 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 396 | 0.030 |
Why?
|
| Hemosiderosis | 1 | 1974 | 7 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 127 | 0.030 |
Why?
|
| Opossums | 2 | 1985 | 7 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 425 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1993 | 31 | 0.030 |
Why?
|
| Splenomegaly | 2 | 1977 | 13 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 1988 | 37 | 0.030 |
Why?
|
| Pyrazoles | 3 | 1973 | 190 | 0.030 |
Why?
|
| Exercise Test | 1 | 1994 | 242 | 0.030 |
Why?
|
| Fats | 1 | 1973 | 8 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 1994 | 236 | 0.030 |
Why?
|
| History, 19th Century | 1 | 1993 | 95 | 0.030 |
Why?
|
| Diagnostic Errors | 2 | 1987 | 100 | 0.030 |
Why?
|
| Peptides | 3 | 1976 | 455 | 0.030 |
Why?
|
| Respiration | 2 | 1990 | 91 | 0.030 |
Why?
|
| Lung Diseases | 1 | 1994 | 175 | 0.030 |
Why?
|
| Nociceptors | 1 | 1992 | 9 | 0.030 |
Why?
|
| Head | 1 | 1993 | 59 | 0.030 |
Why?
|
| Neurofibroma | 1 | 1992 | 11 | 0.030 |
Why?
|
| Thoracotomy | 1 | 1992 | 25 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 904 | 0.030 |
Why?
|
| Collateral Circulation | 4 | 1969 | 34 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 25 | 0.020 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 1991 | 14 | 0.020 |
Why?
|
| Secretin | 3 | 1979 | 18 | 0.020 |
Why?
|
| Colon | 2 | 1974 | 168 | 0.020 |
Why?
|
| Food Preferences | 1 | 1991 | 46 | 0.020 |
Why?
|
| Thoracic Diseases | 2 | 1982 | 10 | 0.020 |
Why?
|
| Ileocecal Valve | 1 | 1970 | 3 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 1971 | 72 | 0.020 |
Why?
|
| Butylamines | 1 | 1990 | 2 | 0.020 |
Why?
|
| Hepatitis | 3 | 1969 | 25 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 1990 | 39 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1990 | 14 | 0.020 |
Why?
|
| Esophageal and Gastric Varices | 3 | 1972 | 47 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1996 | 551 | 0.020 |
Why?
|
| Supination | 1 | 1990 | 2 | 0.020 |
Why?
|
| Solutions | 1 | 1990 | 115 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1990 | 351 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 532 | 0.020 |
Why?
|
| Beds | 1 | 1989 | 13 | 0.020 |
Why?
|
| Scalp | 1 | 1990 | 47 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1990 | 152 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1990 | 78 | 0.020 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 2009 | 5 | 0.020 |
Why?
|
| Weight Lifting | 1 | 1989 | 15 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 95 | 0.020 |
Why?
|
| Emergencies | 1 | 1989 | 107 | 0.020 |
Why?
|
| Bicycling | 1 | 1989 | 39 | 0.020 |
Why?
|
| Secretory Rate | 2 | 1979 | 11 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 1991 | 259 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2009 | 35 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1993 | 689 | 0.020 |
Why?
|
| Portal Vein | 3 | 1978 | 46 | 0.020 |
Why?
|
| Dimaprit | 1 | 1988 | 1 | 0.020 |
Why?
|
| Photofluorography | 1 | 2008 | 3 | 0.020 |
Why?
|
| Thiourea | 1 | 1988 | 16 | 0.020 |
Why?
|
| Alcohol Drinking | 2 | 1991 | 805 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 1989 | 73 | 0.020 |
Why?
|
| Medical Records | 1 | 1989 | 121 | 0.020 |
Why?
|
| Hypertension, Renal | 2 | 1965 | 29 | 0.020 |
Why?
|
| Plants, Edible | 1 | 1988 | 3 | 0.020 |
Why?
|
| Hypertension, Renovascular | 2 | 1965 | 47 | 0.020 |
Why?
|
| Dyspnea | 1 | 2009 | 87 | 0.020 |
Why?
|
| Body Water | 2 | 1986 | 35 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1989 | 157 | 0.020 |
Why?
|
| Chagas Disease | 1 | 1988 | 8 | 0.020 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1988 | 7 | 0.020 |
Why?
|
| Insulin | 1 | 1971 | 619 | 0.020 |
Why?
|
| Nausea | 2 | 1984 | 47 | 0.020 |
Why?
|
| Connective Tissue Diseases | 1 | 1988 | 18 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 219 | 0.020 |
Why?
|
| Bread | 1 | 2007 | 2 | 0.020 |
Why?
|
| Gastric Dilatation | 1 | 1967 | 3 | 0.020 |
Why?
|
| Homosexuality | 2 | 1965 | 10 | 0.020 |
Why?
|
| Leukocytosis | 1 | 1987 | 13 | 0.020 |
Why?
|
| Neurotic Disorders | 2 | 1965 | 13 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 507 | 0.020 |
Why?
|
| Optical Fibers | 1 | 1987 | 7 | 0.020 |
Why?
|
| Sodium | 3 | 1974 | 161 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1987 | 6 | 0.020 |
Why?
|
| Pentetic Acid | 1 | 1987 | 18 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 1990 | 419 | 0.020 |
Why?
|
| Long-Term Care | 1 | 1987 | 53 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 368 | 0.020 |
Why?
|
| Meprobamate | 1 | 1967 | 1 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1967 | 104 | 0.020 |
Why?
|
| Coma | 1 | 1967 | 17 | 0.020 |
Why?
|
| Hydrostatic Pressure | 1 | 1987 | 11 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 954 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1987 | 74 | 0.020 |
Why?
|
| Online Systems | 1 | 1986 | 20 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 1967 | 30 | 0.020 |
Why?
|
| Gold Colloid, Radioactive | 1 | 1966 | 1 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1987 | 95 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1966 | 20 | 0.020 |
Why?
|
| Oklahoma | 1 | 2006 | 18 | 0.020 |
Why?
|
| Xerostomia | 1 | 1986 | 24 | 0.020 |
Why?
|
| Dietary Proteins | 3 | 1975 | 51 | 0.020 |
Why?
|
| Drainage | 1 | 1967 | 133 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 1986 | 44 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1988 | 249 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1986 | 134 | 0.020 |
Why?
|
| Hydrogen | 1 | 1986 | 35 | 0.020 |
Why?
|
| Theophylline | 1 | 1985 | 22 | 0.020 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 1965 | 1 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1985 | 47 | 0.020 |
Why?
|
| Demeclocycline | 1 | 1965 | 2 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 1965 | 5 | 0.020 |
Why?
|
| Photosensitivity Disorders | 1 | 1965 | 7 | 0.020 |
Why?
|
| Toxicology | 1 | 1965 | 14 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 334 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1985 | 92 | 0.020 |
Why?
|
| Vasopressins | 1 | 1965 | 33 | 0.020 |
Why?
|
| Liver Diseases, Parasitic | 1 | 1965 | 1 | 0.020 |
Why?
|
| Psychotherapy | 2 | 1965 | 253 | 0.020 |
Why?
|
| Drug Therapy | 1 | 1965 | 71 | 0.020 |
Why?
|
| Blood | 1 | 1965 | 40 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1994 | 2223 | 0.020 |
Why?
|
| Data Collection | 1 | 1986 | 420 | 0.020 |
Why?
|
| Menstruation | 1 | 1984 | 20 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1975 | 79 | 0.020 |
Why?
|
| Intestinal Diseases, Parasitic | 2 | 1974 | 7 | 0.020 |
Why?
|
| Intestinal Polyps | 2 | 1974 | 15 | 0.020 |
Why?
|
| Transvestism | 1 | 1964 | 2 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1984 | 52 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 1987 | 419 | 0.010 |
Why?
|
| Silicones | 1 | 1984 | 32 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1984 | 7 | 0.010 |
Why?
|
| Hydralazine | 1 | 1984 | 12 | 0.010 |
Why?
|
| Suction | 1 | 1984 | 33 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 2324 | 0.010 |
Why?
|
| Stomach Diseases | 1 | 1984 | 22 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 1984 | 38 | 0.010 |
Why?
|
| Vegetables | 2 | 1975 | 76 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1986 | 601 | 0.010 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1964 | 88 | 0.010 |
Why?
|
| Kidney | 2 | 1965 | 945 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1980 | 29 | 0.010 |
Why?
|
| Alprostadil | 1 | 1982 | 20 | 0.010 |
Why?
|
| Kinetics | 2 | 1975 | 1047 | 0.010 |
Why?
|
| Phobic Disorders | 1 | 1964 | 227 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1983 | 137 | 0.010 |
Why?
|
| Cell Separation | 1 | 1983 | 132 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1990 | 1615 | 0.010 |
Why?
|
| Injections, Subcutaneous | 2 | 1975 | 87 | 0.010 |
Why?
|
| Pain Management | 1 | 1984 | 186 | 0.010 |
Why?
|
| Neck Muscles | 1 | 1982 | 6 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1985 | 313 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1965 | 307 | 0.010 |
Why?
|
| Reoperation | 1 | 1984 | 467 | 0.010 |
Why?
|
| Body Composition | 1 | 2003 | 119 | 0.010 |
Why?
|
| Self Care | 1 | 2005 | 253 | 0.010 |
Why?
|
| Burns, Chemical | 1 | 1982 | 7 | 0.010 |
Why?
|
| Rats | 1 | 1990 | 5300 | 0.010 |
Why?
|
| Naval Medicine | 2 | 1975 | 8 | 0.010 |
Why?
|
| Ice Cream | 1 | 1981 | 1 | 0.010 |
Why?
|
| Ion Channels | 1 | 1982 | 72 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1982 | 193 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1981 | 3 | 0.010 |
Why?
|
| Leiomyoma | 1 | 1981 | 28 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1982 | 57 | 0.010 |
Why?
|
| Vomiting | 1 | 1981 | 56 | 0.010 |
Why?
|
| Xenon | 2 | 1972 | 4 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1982 | 102 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1981 | 27 | 0.010 |
Why?
|
| Energy Transfer | 1 | 2001 | 25 | 0.010 |
Why?
|
| Radio Waves | 1 | 2001 | 21 | 0.010 |
Why?
|
| Health Surveys | 1 | 2003 | 489 | 0.010 |
Why?
|
| Liver Function Tests | 2 | 1972 | 114 | 0.010 |
Why?
|
| Radioisotopes | 2 | 1972 | 40 | 0.010 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1980 | 26 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1981 | 89 | 0.010 |
Why?
|
| Arbaprostil | 1 | 1980 | 1 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1980 | 13 | 0.010 |
Why?
|
| Fever | 1 | 1980 | 96 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1980 | 42 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1986 | 215 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1964 | 621 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1985 | 866 | 0.010 |
Why?
|
| Phenolsulfonphthalein | 1 | 1979 | 2 | 0.010 |
Why?
|
| Dye Dilution Technique | 1 | 1979 | 3 | 0.010 |
Why?
|
| Somatostatin | 1 | 1979 | 36 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1979 | 19 | 0.010 |
Why?
|
| Glucagon | 1 | 1979 | 22 | 0.010 |
Why?
|
| Wounds, Penetrating | 1 | 1999 | 45 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1980 | 205 | 0.010 |
Why?
|
| Anorexia | 1 | 1979 | 7 | 0.010 |
Why?
|
| Alcoholism | 1 | 1988 | 1109 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1979 | 22 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1979 | 24 | 0.010 |
Why?
|
| Pyloric Stenosis | 1 | 1978 | 5 | 0.010 |
Why?
|
| Spleen | 2 | 1977 | 301 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2455 | 0.010 |
Why?
|
| Xenon Radioisotopes | 1 | 1978 | 6 | 0.010 |
Why?
|
| Angiography | 2 | 1972 | 194 | 0.010 |
Why?
|
| Motor Activity | 1 | 1981 | 621 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1979 | 132 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1977 | 4 | 0.010 |
Why?
|
| Ulnar Nerve | 1 | 1977 | 7 | 0.010 |
Why?
|
| Median Nerve | 1 | 1977 | 5 | 0.010 |
Why?
|
| Reflex | 1 | 1977 | 21 | 0.010 |
Why?
|
| Ketamine | 1 | 1978 | 57 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1977 | 22 | 0.010 |
Why?
|
| Skin Temperature | 1 | 1977 | 24 | 0.010 |
Why?
|
| Rupture | 1 | 1977 | 29 | 0.010 |
Why?
|
| Lipids | 1 | 1979 | 298 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1977 | 107 | 0.010 |
Why?
|
| Depression | 1 | 1964 | 943 | 0.010 |
Why?
|
| Medication Errors | 1 | 1978 | 116 | 0.010 |
Why?
|
| Pylorus | 1 | 1976 | 6 | 0.010 |
Why?
|
| Hospital Departments | 1 | 1976 | 15 | 0.010 |
Why?
|
| Meat | 2 | 1975 | 34 | 0.010 |
Why?
|
| Anesthesia | 1 | 1978 | 120 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 1976 | 10 | 0.010 |
Why?
|
| Hemochromatosis | 1 | 1976 | 13 | 0.010 |
Why?
|
| Nizatidine | 1 | 1995 | 1 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1976 | 73 | 0.010 |
Why?
|
| Scleroderma, Localized | 1 | 1975 | 19 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 1975 | 31 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1975 | 54 | 0.010 |
Why?
|
| Schistosoma haematobium | 1 | 1974 | 1 | 0.010 |
Why?
|
| Schistosoma mansoni | 1 | 1974 | 4 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1975 | 358 | 0.010 |
Why?
|
| Calcium Carbonate | 1 | 1974 | 7 | 0.010 |
Why?
|
| Gastritis | 1 | 1974 | 12 | 0.010 |
Why?
|
| Semicarbazides | 1 | 1974 | 1 | 0.010 |
Why?
|
| Benzaldehydes | 1 | 1974 | 8 | 0.010 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1974 | 30 | 0.010 |
Why?
|
| Kynurenic Acid | 1 | 1974 | 26 | 0.010 |
Why?
|
| Magnesium | 1 | 1974 | 110 | 0.010 |
Why?
|
| Ethylamines | 1 | 1973 | 1 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1973 | 21 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 1974 | 36 | 0.010 |
Why?
|
| Temperature | 1 | 1975 | 341 | 0.010 |
Why?
|
| Oils | 1 | 1973 | 6 | 0.010 |
Why?
|
| Citrus | 1 | 1973 | 12 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1973 | 165 | 0.010 |
Why?
|
| Milk | 1 | 1973 | 43 | 0.010 |
Why?
|
| Zea mays | 1 | 1973 | 27 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1974 | 420 | 0.010 |
Why?
|
| Proteins | 2 | 1975 | 474 | 0.010 |
Why?
|
| Portography | 1 | 1972 | 1 | 0.010 |
Why?
|
| Phlebography | 1 | 1972 | 31 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1972 | 75 | 0.010 |
Why?
|
| Sodium Chloride | 2 | 1986 | 136 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 128 | 0.010 |
Why?
|
| Hormones | 1 | 1972 | 42 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1972 | 41 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1974 | 299 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1971 | 10 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1977 | 694 | 0.010 |
Why?
|
| Appetite | 1 | 1991 | 16 | 0.010 |
Why?
|
| Sodium Hydroxide | 1 | 1971 | 5 | 0.010 |
Why?
|
| Glucose | 1 | 1972 | 307 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1971 | 59 | 0.010 |
Why?
|
| Diffusion | 1 | 1971 | 90 | 0.010 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1969 | 3 | 0.010 |
Why?
|
| Self Medication | 1 | 1989 | 25 | 0.010 |
Why?
|
| Caprylates | 1 | 1969 | 32 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1969 | 4 | 0.010 |
Why?
|
| Fructose | 1 | 1969 | 51 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1989 | 75 | 0.000 |
Why?
|
| Jejunum | 1 | 1968 | 26 | 0.000 |
Why?
|
| Chromium Isotopes | 1 | 1967 | 2 | 0.000 |
Why?
|
| Infectious Mononucleosis | 1 | 1967 | 7 | 0.000 |
Why?
|
| Suspensions | 1 | 1987 | 11 | 0.000 |
Why?
|
| Intestinal Perforation | 1 | 1968 | 35 | 0.000 |
Why?
|
| Malaria | 1 | 1967 | 26 | 0.000 |
Why?
|
| Intubation | 1 | 1987 | 20 | 0.000 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1967 | 20 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1968 | 86 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1967 | 6 | 0.000 |
Why?
|
| Ethanol | 1 | 1974 | 893 | 0.000 |
Why?
|
| Arthritis | 1 | 1987 | 53 | 0.000 |
Why?
|
| Primary Myelofibrosis | 1 | 1966 | 3 | 0.000 |
Why?
|
| Pheochromocytoma | 1 | 1966 | 22 | 0.000 |
Why?
|
| Paraphilic Disorders | 1 | 1965 | 4 | 0.000 |
Why?
|
| Urography | 1 | 1964 | 21 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1987 | 402 | 0.000 |
Why?
|
| Renal Artery Obstruction | 1 | 1964 | 29 | 0.000 |
Why?
|
| Kidney Function Tests | 1 | 1964 | 114 | 0.000 |
Why?
|
| Nephrectomy | 1 | 1964 | 103 | 0.000 |
Why?
|
| Meperidine | 1 | 1983 | 5 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1964 | 124 | 0.000 |
Why?
|
| Estradiol | 1 | 1984 | 176 | 0.000 |
Why?
|
| Rest | 1 | 1979 | 78 | 0.000 |
Why?
|
| Glycine | 1 | 1979 | 89 | 0.000 |
Why?
|
| Models, Biological | 1 | 1981 | 981 | 0.000 |
Why?
|
| Niridazole | 1 | 1974 | 1 | 0.000 |
Why?
|
| Parasite Egg Count | 1 | 1974 | 5 | 0.000 |
Why?
|
| Sigmoidoscopy | 1 | 1974 | 38 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1974 | 164 | 0.000 |
Why?
|
| Sulfobromophthalein | 1 | 1971 | 2 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1971 | 71 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1971 | 87 | 0.000 |
Why?
|
| Alanine Transaminase | 1 | 1971 | 137 | 0.000 |
Why?
|
| Administration, Rectal | 1 | 1969 | 26 | 0.000 |
Why?
|
| Gold Isotopes | 1 | 1969 | 1 | 0.000 |
Why?
|
| Cobalt Isotopes | 1 | 1968 | 1 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1969 | 168 | 0.000 |
Why?
|
| Intestinal Neoplasms | 1 | 1968 | 30 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1969 | 306 | 0.000 |
Why?
|
| Length of Stay | 1 | 1971 | 780 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1966 | 765 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1969 | 334 | 0.000 |
Why?
|